[Image source=Yonhap News]

[Image source=Yonhap News]

View original image

[Asia Economy Reporter Son Sun-hee] On the 25th (local time), a portion of the second batch (6.5 million doses) of the Chinese-made novel coronavirus (COVID-19) vaccine was imported into Turkey.


According to local media, 6.5 million doses of the COVID-19 vaccine produced by the Chinese pharmaceutical company Sinovac arrived from Beijing through Istanbul Airport. This is part of the second batch out of the contracted 10 million doses.


Previously, the Turkish government decided to import 50 million doses of Sinovac's COVID-19 vaccine, and on the 30th of last month, 3 million doses of the Sinovac vaccine were imported as the first batch.


The Turkish Ministry of Health has been administering the vaccine since the 14th, starting with healthcare workers, the elderly, and people with disabilities.



However, the Sinovac vaccine has shown a wide range of efficacy from 50% to 90% in different clinical trials, raising doubts about its effectiveness.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing